TRACON Pharmaceuticals (NASDAQ:TCON) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON – Free Report) in a research report released on Monday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “neutral” rating on shares of TRACON Pharmaceuticals in a research note on Monday, July 1st. Check Out Our Latest […]

Leave a Reply

Your email address will not be published.

Previous post Kellanova (NYSE:K) Now Covered by Analysts at StockNews.com
Next post StockNews.com Initiates Coverage on U.S. Global Investors (NASDAQ:GROW)